Palvella Therapeutics Ownership | Who Owns Palvella Therapeutics?

Palvella Therapeutics Ownership Summary

Palvella Therapeutics is owned by 53.47% institutional investors, 17.50% insiders, and 29.03% retail investors. Frazier life sciences management is the largest institutional shareholder, holding 6.54% of PVLA shares.

PVLA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Palvella Therapeutics	53.47%	17.50%	29.03%
Sector	Healthcare Stocks	486.50%	11.08%	-397.59%
Industry	Biotech Stocks	304.14%	11.08%	-215.23%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Frazier life sciences management	722.40K	6.54%	$16.28M
Suvretta capital management	714.46K	6.46%	$16.10M
Bvf inc/il	696.55K	6.30%	$15.70M
Blackrock funding, inc. /de	445.05K	4.03%	$10.03M
Samsara biocapital	339.74K	3.07%	$7.66M
Adams street partners	298.99K	2.71%	$6.74M
Nantahala capital management	250.06K	2.26%	$5.64M
Blue owl capital lp	125.26K	1.13%	$2.82M
Sectoral asset management	95.61K	0.87%	$2.16M
Clio asset management	91.51K	0.83%	$2.06M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Adams street partners	298.99K	4.75%	$6.74M
Clio asset management	91.51K	1.62%	$2.06M
Samsara biocapital	339.74K	1.57%	$7.66M
Sectoral asset management	95.61K	1.42%	$2.16M
Blue owl capital lp	125.26K	0.91%	$2.82M
Frazier life sciences management	722.40K	0.65%	$16.28M
Bvf inc/il	696.55K	0.56%	$15.70M
Suvretta capital management	714.46K	0.49%	$16.10M
Dafna capital management	43.35K	0.27%	$977.06K
Nantahala capital management	250.06K	0.22%	$5.64M

Top Buyers

Holder	Shares	% Assets	Change
Blackrock funding, inc. /de	445.05K	0.00%	334.29K
Sectoral asset management	95.61K	1.42%	95.61K
Clio asset management	91.51K	1.62%	91.51K
J. goldman & co lp	56.29K	0.03%	56.29K
Frazier life sciences management	722.40K	0.65%	32.39K

Top Sellers

Holder	Shares	% Assets	Change
Samsara biocapital	339.74K	1.57%	-339.74K
Opaleye management	-	-	-172.36K
Adams street partners	298.99K	4.75%	-110.68K
Blue owl capital lp	125.26K	0.91%	-15.00K
Balyasny asset management	-	-	-8.18K

New Positions

Holder	Shares	% Assets	Change	Value
Sectoral asset management	95.61K	1.42%	95.61K	$2.16M
Clio asset management	91.51K	1.62%	91.51K	$2.06M
J. goldman & co lp	56.29K	0.03%	56.29K	$1.27M
Xtx topco	17.70K	0.02%	17.70K	$398.98K
Fred alger management	13.54K	0.00%	13.54K	$305.24K

Sold Out

Holder	Change
Balyasny asset management	-8.18K
Opaleye management	-172.36K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	65	62.50%	5,909,711	15.35%	53	2.47%	44	91.30%	9	125.00%
Mar 31, 2025	40	21.21%	5,124,167	27.05%	230	0.70%	24	71.43%	4	-33.33%
Dec 31, 2024	33	37.50%	4,033,115	565.98%	181	24.48%	14	40.00%	6	-
Sep 30, 2024	24	26.32%	605,591	67.17%	27	10.27%	10	-47.37%	6	-
Jun 30, 2024	19	-	362,269	-	16	-	19	-	-	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Apr 09, 2025	JENKINS GEORGE M	-	Buy	$50.33K
Apr 09, 2025	JENKINS GEORGE M	-	Buy	$50.47K
Dec 18, 2024	JENKINS GEORGE M	-	Buy	$51.72K

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	2	-
2025 Q1	-	-
2024 Q4	1	-

PVLA Ownership FAQ

Who Owns Palvella Therapeutics?

Palvella Therapeutics shareholders are primarily institutional investors at 53.47%, followed by 17.50% insiders and 29.03% retail investors. The average institutional ownership in Palvella Therapeutics's industry, Biotech Stocks , is 304.14%, which Palvella Therapeutics falls below.

Who owns the most shares of Palvella Therapeutics?

Palvella Therapeutics’s largest shareholders are Frazier life sciences management (722.4K shares, 6.54%), Suvretta capital management (714.46K shares, 6.46%), and Bvf inc/il (696.56K shares, 6.30%). Together, they hold 19.30% of Palvella Therapeutics’s total shares outstanding.

Does Blackrock own Palvella Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Palvella Therapeutics.

Who is Palvella Therapeutics’s biggest shareholder by percentage of total assets invested?

Adams street partners is Palvella Therapeutics’s biggest shareholder by percentage of total assets invested, with 4.75% of its assets in 298.99K Palvella Therapeutics shares, valued at 6.74M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools